Liver cancer is the 3rd most frequent cause of cancer related death worldwide and shows rising incidence. It is the most relevant paradigm of viral, metabolic, and inflammation induced tumourigenesis, but this ideal model situation has not led to satisfactory clinical translation so far. The SFB/TRR77 aims to investigate the molecular mechanisms that induce and promote liver cancer and to explore their potential for preventive, diagnostic, and therapeutic application. It is the worldwide largest research consortium addressing liver cancer and already in its first funding period made a significant national and international impact by its research data, translational efforts, conferences and workshops, as well as induction of clinical structures at both locations.
HCC Conference in 2012
Have a look at the pictures and get an impression of the HCC Conference in Heidelberg (05.-07.07.2012), initiated and organizied by the SFB/TRR77 HERE!!! A report about the conference can also be seen in the EACR yearbook. Just follow the link.